Atlas Trials

Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia

Clinical trial NCT05233761 · COMPLETED

Trial details

NCT number
NCT05233761
Sponsor
Defined Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Insomnia
Start date
2022-02-18
Primary completion
2022-07-02
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.